Founded in Paris in 1920, Gide is a leading international law firm with 12 offices spread throughout the world.
Gide is physically present in six regions of the world, with 11 offices, enabling it to act on cases globally.
9 November 2016
Deals | France & China | M&A
Gide is advising Inner Mongolia Furui Medical Science Co., Ltd. (FURUI), a Chinese company listed on ChiNext GEM Board and dedicated to pharmaceutical, diagnosis and medical services, on its investment in MEDIAN Technologies, a company listed on Alternext specialized in medical imaging software and services dedicated to oncology clinical trials, cancer screening and clinical practice.
The transaction, which is subject to customary conditions precedent, will consist in a capital increase of MEDIAN Technologies at a price of €13 per share, representing a total amount of €19,599,996 reserved to Furui Medical Science Company Luxembourg, a wholly owned subsidiary of FURUI. The completion of the transaction will allow Furui Medical Science Company Luxembourg to hold 13.01% of the share capital and 13.03% of the voting rights of MEDIAN Technologies.
The Gide team advising FURUI on this transaction comprises Antoine Tézenas du Montcel (partner), Régis Henry and Elise Bernard in Paris and Ronan Diot (counsel) in Beijing.
MEDIAN Technologies was advised by PDGB Avocats.
